Form D · Other

Bodhi Tree Biotechnology Inc

Danville, CA · CIK 0002041531

Offering snapshot reported Jun 5, 2025 · SEC filing

Reported sold
$48.2K
Offering amount: $48.2K
Investors reported
32
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 15, 2024
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$165K$331KApr 15, 2025: $330,780.00Apr 15, 2025Jun 5, 2025: $48,200.00Jun 5, 2025

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$330,780 → $48,200

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 5, 2025Amendment$48,200-$282,580vs Apr 15, 202532SEC filing
Apr 15, 2025Initial$330,780No comparison32SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-543738
In two separate private placement transactions, from March to September 2024, we sold 14,344,292 shares of our common stock to 32 accredited investors for total proceeds of $48,200, used for working capital.

Source: Form D, filed Jun 5, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jonathan Ginsberg Director
Xiaohang Wang Director, Executive
Juan Ye Director

Issuer details

Industry: Other (See others in industry)

Address:
4125 Blackhawk Plaza Circle Suite 172
Danville, CA, 93506